{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:40:19Z","timestamp":1777948819484,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,3]]},"DOI":"10.7759\/cureus.108168","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T20:56:55Z","timestamp":1777841815000},"source":"Crossref","is-referenced-by-count":0,"title":["Cranial and Systemic Manifestations of Giant Cell Arteritis: Two Sides of the Same Coin"],"prefix":"10.7759","author":[{"given":"L\u00e9onard","family":"Zufferey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chlo\u00e9","family":"Manca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Ouamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Garin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Moi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2413449","article-title":"A phase 3 trial of upadacitinib for giant-cell arteritis","volume":"392","author":"Blockmans D","year":"2025","unstructured":"Blockmans D, Penn SK, Setty AR, et al.. A phase 3 trial of upadacitinib for giant-cell arteritis. N Engl J Med. 2025, 392:2013-24. 10.1056\/NEJMoa2413449","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(22)00260-0","article-title":"Pan American League of Associations for Rheumatology guidelines for the treatment of giant cell arteritis","volume":"4","author":"Scolnik M","year":"2022","unstructured":"Scolnik M, Brance ML, Fern\u00e1ndez-\u00c1vila DG, et al.. Pan American League of Associations for Rheumatology guidelines for the treatment of giant cell arteritis. Lancet Rheumatol. 2022, 4:864-72. 10.1016\/s2665-9913(22)00260-0","journal-title":"Lancet Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.10.025","article-title":"Giant cell arteritis: update on clinical manifestations, diagnosis, and management","volume":"107","author":"Farina N","year":"2023","unstructured":"Farina N, Tomelleri A, Campochiaro C, Dagna L. Giant cell arteritis: update on clinical manifestations, diagnosis, and management. Eur J Intern Med. 2023, 107:17-26. 10.1016\/j.ejim.2022.10.025","journal-title":"Eur J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew273","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco C","year":"2017","unstructured":"Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford). 2017, 56:506-15. 10.1093\/rheumatology\/kew273","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200865","article-title":"Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography","volume":"71","author":"Prieto-Gonz\u00e1lez S","year":"2012","unstructured":"Prieto-Gonz\u00e1lez S, Arguis P, Garc\u00eda-Mart\u00ednez A, et al.. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis. 2012, 71:1170-6. 10.1136\/annrheumdis-2011-200865","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac478","article-title":"Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis","volume":"62","author":"Bull Haaversen AC","year":"2023","unstructured":"Bull Haaversen AC, Brekke LK, Kermani TA, Molberg \u00d8, Diamantopoulos AP. Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis. Rheumatology (Oxford). 2023, 62:1887-94. 10.1093\/rheumatology\/keac478","journal-title":"Rheumatology (Oxford)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte C","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC, et al.. 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022, 81:1647-53. 10.1136\/ard-2022-223480","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit F","year":"2016","unstructured":"Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016, 315:2442-58. 10.1001\/jama.2016.5444","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani C","year":"2008","unstructured":"Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008, 372:234-45. 10.1016\/s0140-6736(08)61077-6","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(24)00024-9","article-title":"Cranial involvement in giant cell arteritis","volume":"6","author":"Bosch P","year":"2024","unstructured":"Bosch P, Espigol-Frigol\u00e9 G, Cid MC, Mollan SP, Schmidt WA. Cranial involvement in giant cell arteritis. Lancet Rheumatol. 2024, 6:384-96. 10.1016\/s2665-9913(24)00024-9","journal-title":"Lancet Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0871-z","article-title":"Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis","volume":"15","author":"Prior JA","year":"2017","unstructured":"Prior JA, Ranjbar H, Belcher J, Mackie SL, Helliwell T, Liddle J, Mallen CD. Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis. BMC Med. 2017, 15:120. 10.1186\/s12916-017-0871-z","journal-title":"BMC Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.98","article-title":"Visual loss and other cranial ischaemic complications in giant cell arteritis","volume":"13","author":"Soriano A","year":"2017","unstructured":"Soriano A, Muratore F, Pipitone N, Boiardi L, Cimino L, Salvarani C. Visual loss and other cranial ischaemic complications in giant cell arteritis. Nat Rev Rheumatol. 2017, 13:476-84. 10.1038\/nrrheum.2017.98","journal-title":"Nat Rev Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202408","article-title":"Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis","volume":"72","author":"Kermani TA","year":"2013","unstructured":"Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis. 2013, 72:1989-94. 10.1136\/annrheumdis-2012-202408","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003379","article-title":"Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations","volume":"9","author":"Bosch P","year":"2023","unstructured":"Bosch P, Bond M, Dejaco C, et al.. Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations. RMD Open. 2023, 9:10.1136\/rmdopen-2023-003379","journal-title":"RMD Open"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae171","article-title":"A direct comparison in diagnostic performance of CDUS, FDG-PET\/CT and MRI in patients suspected of giant cell arteritis","volume":"64","author":"van Nieuwland M","year":"2025","unstructured":"van Nieuwland M, Colin EM, Vermeer M, et al.. A direct comparison in diagnostic performance of CDUS, FDG-PET\/CT and MRI in patients suspected of giant cell arteritis. Rheumatology (Oxford). 2025, 64:1392-9. 10.1093\/rheumatology\/keae171","journal-title":"Rheumatology (Oxford)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.10","article-title":"Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients","volume":"30","author":"Maleszewski JJ","year":"2017","unstructured":"Maleszewski JJ, Younge BR, Fritzlen JT, Hunder GG, Goronzy JJ, Warrington KJ, Weyand CM. Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients. Mod Pathol. 2017, 30:788-96. 10.1038\/modpathol.2017.10","journal-title":"Mod Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-005132","article-title":"Does tocilizumab eliminate inflammation in GCA? A cohort study on repeated temporal artery biopsies","volume":"10","author":"Ricordi C","year":"2024","unstructured":"Ricordi C, Marvisi C, Macchioni P, et al.. Does tocilizumab eliminate inflammation in GCA? A cohort study on repeated temporal artery biopsies. RMD Open. 2024, 10:10.1136\/rmdopen-2024-005132","journal-title":"RMD Open"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.04.027","article-title":"Treatment of giant cell arteritis","volume":"165","author":"Gonz\u00e1lez-Gay M\u00c1","year":"2019","unstructured":"Gonz\u00e1lez-Gay M\u00c1, Pina T, Prieto-Pe\u00f1a D, Calderon-Goercke M, Gualillo O, Casta\u00f1eda S. Treatment of giant cell arteritis. Biochem Pharmacol. 2019, 165:230-9. 10.1016\/j.bcp.2019.04.027","journal-title":"Biochem Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1066503","article-title":"Current developments in the diagnosis and treatment of giant cell arteritis","volume":"9","author":"Szekeres D","year":"2022","unstructured":"Szekeres D, Al Othman B. Current developments in the diagnosis and treatment of giant cell arteritis. Front Med (Lausanne). 2022, 9:1066503. 10.3389\/fmed.2022.1066503","journal-title":"Front Med (Lausanne)"},{"key":"ref20","article-title":"MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial [abstract]","volume":"77","author":"Samson M","year":"2025","unstructured":"Samson M, Bourredjem A, Outh R, et al.. MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial [abstract]. Arthritis Rheumatol. 2025, 77:","journal-title":"Arthritis Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/477863-cranial-and-systemic-manifestations-of-giant-cell-arteritis-two-sides-of-the-same-coin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T20:56:55Z","timestamp":1777841815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/477863-cranial-and-systemic-manifestations-of-giant-cell-arteritis-two-sides-of-the-same-coin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.108168","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,3]]}}}